Annual Report 2023 and 2024
Released
Released
Announcement PDF
Tetratherix Pty Ltd
ABN 72 607 771 077
Annual Report - 30 June 2023
Tetratherix Pty Ltd
Directors' report
30 June 2023
The directors present their report, together with the financial statements, on the consolidated entity (referred to hereafter as
the 'consolidated entity' or 'group') consisting of Tetratherix Pty Ltd (referred to hereafter as the 'company' or 'parent entity')
and the entities it controlled at the end of, or during, the year ended 30 June 2023.
Directors
The following persons were directors of Tetratherix Pty Ltd during the whole of the financial year and up to the date of this
report, unless otherwise stated:
Ali Fathi
David Harold Bottomley
William Anthony Knox
Terrence Abrams (resigned 26 May 2023)
Principal activities
Tetratherix is a biomedical company that has developed an advanced biomaterial platform called Tetramatrix, a proprietary
fluid matrix that induces minimal foreign body reaction. The principal activities include development programs in the areas of
regenerative medicine and commercialising medical device technology across multiple applications including Skeletal
Reconstruction, Surgical Spacing and Tissue Healing.
Dividends
There were no dividends paid, recommended or declared during the current or previous financial year.
Review of operations
The loss for the consolidated entity after providing for income tax amounted to $1,820,486 (30 June 2022: $1,535,276).
Significant changes in the state of affairs
There were no significant changes in the state of affairs of the consolidated entity during the financial year.
Matters subsequent to the end of the financial year
Preference shares to the value of $2,907,965 (number of shares: 6587) were issued subsequent to year end.
Furthermore, $2.5 million was raised in November 2024 in terms of safe notes and a further $10 million was secured in
December 2024.
No other matter or circumstance has arisen since 30 June 2023 that has significantly affected, or may significantly affect the
consolidated entity's operations, the results of those operations, or the consolidated entity's state of affairs in future financial
years.
Likely developments and expected results of operations
Notwithstanding the group's loss of $1,820,486 (2022: $1,535,276) net liabilities of $4,555,934 (2022: $3,136,591), the annual
report has been prepared on a going concern basis.
The directors note that subsequent to year-end, the group successfully completed a capital raise of $2.5 million in November
2024 and secured $10 million in December 2024 which, significantly improved the company’s liquidity position. The proceeds
from the capital raise are intended to support ongoing operations, fund strategic growth initiatives, and meet short-term working
capital requirements.
The group's ability to continue as a going concern is contingent upon additional capital raising activities. The company is
planning an Initial Public Offering (IPO), and given its past success and feedback from potential investors at the Non Deal
Roadshow (NDR), the directors are confident in securing the necessary funding. Whilst the directors are confident in securing
the necessary funding, there remains material uncertainty that may cast significant doubt on the group's ability to continue as
a going concern. Should the IPO not proceed as expected, the group may be required to seek alternative fundings sources or
continue other strategic options to continue as a going concern.
The group directors have considered this uncertainty and have prepared a comprehensive plan to manage the risk associated
with the IPO. A scenario was developed where capital raising was delayed until the end of 20 months and still showed a going
concern position. This provides contingency to mitigate against potential delays with the IPO or alternate capital raising.
Environmental regulation
The consolidated entity is not subject to any significant environmental regulation under Australian Commonwealth or State
law.
1
Tetratherix Pty Ltd
Directors' report
30 June 2023
Share under option
Unissued ordinary shares of Tetratherix Pty Ltd under option at the date of this report are as follows:
Grant date
01/06/2019
02/07/2020
13/08/2021
13/08/2021
15/10/2021
26/04/2022
Expiry date
01/06/2021
01/07/2026
01/09/2023
01/09/2024
01/11/2024
01/05/2026
Exercise price
$0.10
$1.00
$0.50
$0.50
$1.00
$1.00
Number under option
724,430
66,384
167,922
515,985
25,072
26,920
1,536,089
Shares issued on the exercise of options
There were no ordinary shares of Tetratherix Pty Ltd issued on the exercise of options during the year ended 30 June 2023
and up to the date of this report. Further detail noted as per note 17.
Meetings of directors
The number of meetings of the company's Board of Directors ('the Board') held during the year ended 30 June 2023, and the
number of meetings attended by each director were:
Full Board
Attended
Held
Ali Fathi
David Harold Bottomley
William Anthony Knox
Terrence Abrams
2
2
2
2
2
2
2
2
Held: represents the number of meetings held during the time the director held office.
Indemnity and insurance of officers
The company has indemnified the directors and executives of the company for costs incurred, in their capacity as a director
or executive, for which they may be held personally liable, except where there is a lack of good faith.
During the financial year, the company paid a premium in respect of a contract to insure the directors and executives of the
company against a liability to the extent permitted by the Corporations Act 2001. The contract of insurance prohibits disclosure
of the nature of the liability and the amount of the premium.
Proceedings on behalf of the company
No person has applied to the Court under section 237 of the Corporations Act 2001 for leave to bring proceedings on behalf
of the company, or to intervene in any proceedings to which the company is a party for the purpose of taking responsibility on
behalf of the company for all or part of those proceedings.
Auditor's independence declaration
A copy of the auditor's independence declaration as required under section 307C of the Corporations Act 2001 is set out
immediately after this directors' report.
Auditor
Nexia Sydney Audit Pty Ltd has been appointed to act as auditors in accordance with section 327 of the Corporations Act
2001.
2
Tetratherix Pty Ltd
Directors' report
30 June 2023
This report is made in accordance with a resolution of directors, pursuant to section 298(2)(a) of the Corporations Act 2001.
On behalf of the directors
___________________________
___________________ 2025
3
To the Board of Directors of Tetratherix Pty Ltd
Auditor’s Independence Declaration under section 307C of the Corporations Act 2001
As lead audit partner for the audit of the financial statements of Tetratherix Pty Ltd for the financial year ended
30 June 2023, I declare that to the best of my knowledge and belief, there have been no contraventions of:
(a)
the auditor independence requirements of the Corporations Act 2001 in relation to the audit; and
(b)
any applicable code of professional conduct in relation to the audit.
Yours sincerely,
Nexia Sydney Audit Pty Ltd
Erin Tanyag
Director
Dated: 25 February 2025
Tetratherix Pty Ltd
Contents
30 June 2023
Consolidated statement of profit or loss and other comprehensive income
Consolidated statement of financial position
Consolidated statement of changes in equity
Consolidated statement of cash flows
Notes to the consolidated financial statements
Directors' declaration
Independent auditor's report to the members of Tetratherix Pty Ltd
6
7
8
9
10
30
31
General information
The financial statements cover Tetratherix Pty Ltd as a consolidated entity consisting of Tetratherix Pty Ltd and the entities it
controlled at the end of, or during, the year. The financial statements are presented in Australian dollars, which is Tetratherix
Pty Ltd's functional and presentation currency.
Tetratherix Pty Ltd is a proprietary company limited by shares, incorporated and domiciled in Australia. Its registered office
and principal place of business are:
Registered office
Principal place of business
Suite 5307, Level 53
25 Martin Place
Sydney, 2000, NSW
Unit 29, 34-36 Ralph Street
Alexandria, NSW, 2015
A description of the nature of the consolidated entity's operations and its principal activities are included in the directors' report,
which is not part of the financial statements.
The financial statements were authorised for issue, in accordance with a resolution of directors, on 25 February 2025. The
directors have the power to amend and reissue the financial statements.
5
Tetratherix Pty Ltd
Consolidated statement of profit or loss and other comprehensive income
For the year ended 30 June 2023
Note
Revenue
4
Consolidated
Unaudited
2023
2022
$
$
566,279
1,107,826
566,279
1,107,826
Expenses
Employee benefits expense
Depreciation and amortisation expense
Product development expense
Administrative expense
Finance costs
Total expenses
(1,145,612)
(70,675)
(170,000)
(864,590)
(135,888)
(2,386,765)
(949,879)
(78,574)
(187,528)
(1,317,221)
(109,900)
(2,643,102)
Loss before income tax expense
(1,820,486)
(1,535,276)
Total revenue
Income tax expense
5
-
-
Loss after income tax expense for the year
19
(1,820,486)
(1,535,276)
-
-
(1,820,486)
(1,535,276)
Other comprehensive income/(loss) for the year, net of tax
Total comprehensive loss for the year
The above consolidated statement of profit or loss and other comprehensive income should be read in conjunction with the
accompanying notes
6
Tetratherix Pty Ltd
Consolidated statement of financial position
As at 30 June 2023
Note
Consolidated
Unaudited
2023
2022
$
$
Assets
Current assets
Cash and cash equivalents
Trade and other receivables
Other assets
Total current assets
6
7
9
260,575
560,343
104,892
925,810
7,712
863,832
77,382
948,926
Non-current assets
Property, plant and equipment
Right-of-use assets
Total non-current assets
10
8
267,400
202,048
469,448
302,274
235,262
537,536
1,395,258
1,486,462
Total assets
Liabilities
Current liabilities
Trade and other payables
Borrowings
Lease liabilities
Employee benefits
Preference shares
Total current liabilities
12
13
14
15
16
608,304
488,000
20,885
74,343
2,801,638
3,993,170
72,009
123,875
19,673
50,296
2,500,000
2,765,853
Non-current liabilities
Borrowings
Lease liabilities
Employee benefits
Total non-current liabilities
13
14
15
1,687,725
240,487
29,810
1,958,022
1,573,811
261,371
22,018
1,857,200
Total liabilities
5,951,192
4,623,053
Net liabilities
(4,555,934)
(3,136,591)
1,886,540
1,536,089
(7,978,563)
1,886,540
1,134,946
(6,158,077)
(4,555,934)
(3,136,591)
Equity
Issued capital
Reserves
Accumulated losses
17
18
19
Total deficiency in equity
The above consolidated statement of financial position should be read in conjunction with the accompanying notes
7
Tetratherix Pty Ltd
Consolidated statement of changes in equity
For the year ended 30 June 2023
Issued
Options
Accumulated
Consolidated
capital
$
reserves
$
losses
$
Total
deficiency in
equity
$
Balance at 1 July 2021
1,886,540
790,815
(4,622,801)
(1,945,446)
Loss after income tax expense for the year
Other comprehensive income/(loss) for the year, net of tax
-
-
(1,535,276)
-
(1,535,276)
-
Total comprehensive loss for the year
-
-
(1,535,276)
(1,535,276)
Transactions with owners in their capacity as owners:
Share based payment
-
344,131
-
344,131
1,886,540
1,134,946
(6,158,077)
(3,136,591)
Issued
Options
Accumulated
Consolidated
capital
$
reserves
$
losses
$
Total
deficiency in
equity
$
Balance at 1 July 2022
1,886,540
1,134,946
(6,158,077)
(3,136,591)
Loss after income tax expense for the year
Other comprehensive income/(loss) for the year, net of tax
-
-
(1,820,486)
-
(1,820,486)
-
Total comprehensive loss for the year
-
-
(1,820,486)
(1,820,486)
Transactions with owners in their capacity as owners:
Share-based payment (note 30)
-
401,143
-
401,143
1,886,540
1,536,089
(7,978,563)
(4,555,934)
Balance at 30 June 2022
Balance at 30 June 2023
The above consolidated statement of changes in equity should be read in conjunction with the accompanying notes
8
Tetratherix Pty Ltd
Consolidated statement of cash flows
For the year ended 30 June 2023
Note
Cash flows from operating activities
Receipts from customers (inclusive of GST)
Payments to suppliers (inclusive of GST)
Government grants received
Interest and other finance costs paid
Consolidated
Unaudited
2023
2022
$
$
38,621
(1,237,806)
832,918
264,179
(1,964,136)
895,206
(366,267)
(21,974)
(804,751)
(17,470)
Net cash used in operating activities
30
(388,241)
(822,221)
Cash flows from investing activities
Payments for property, plant and equipment
10
(4,987)
-
(4,987)
-
301,638
364,125
(19,672)
500,000
29,995
(37,968)
Net cash from financing activities
646,091
492,027
Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the financial year
252,863
7,712
(330,194)
337,906
260,575
7,712
Net cash used in investing activities
Cash flows from financing activities
Proceeds from issue of preference shares
Proceeds from borrowings
Repayment of lease liabilities
16
Cash and cash equivalents at the end of the financial year
6
The above consolidated statement of cash flows should be read in conjunction with the accompanying notes
9
Tetratherix Pty Ltd
Notes to the consolidated financial statements
30 June 2023
Note 1. Material accounting policy information
The accounting policies that are material to the consolidated entity are set out below. The accounting policies adopted are
consistent with those of the previous financial year, unless otherwise stated.
New or amended Accounting Standards and Interpretations adopted
The consolidated entity has adopted all of the new or amended Accounting Standards and Interpretations issued by the
Australian Accounting Standards Board ('AASB') that are mandatory for the current reporting period.
Any new or amended Accounting Standards or Interpretations that are not yet mandatory have not been early adopted.
Going concern
The company has prepared the financial statements for year ended 30 June 2023 on the going concern basis which assumes
normal business activities and the realisation of assets and settlement of liabilities in the ordinary course of business.
For the year ended 30 June 2023, the group incurred a loss of $1,820,486 (Unaudited 2022: loss
and incurred
operating cash outflows of $388,241 (Unaudited 2022: cash outflows of
As
June 2023, the company had
cash and cash equivalents of $260,575 (Unaudited
and a net assets deficiency
These matters give rise to a material uncertainty that may cast significant doubt on the group's ability to
continue as a going concern.
Despite this, the Directors believe that the going concern assumption remains appropriate due to the following mitigating
factors:
The group has secured commitments from investors of $10 million in December 2024 to ensure sufficient cash inflows
to meet its obligations as they fall due over the next 12 months after signing date of these financial statements.
The group is planning to undertake Initial Public Offering (IPO) within the next 12 months, with a view of raising further
capital. The proceeds from the IPO are expected to strengthen the group’s liquidity position and enable it to continue its
operations and achieve its business objectives. Should the IPO not proceed as expected, the group will be able to seek
alternative fundings sources or continue other strategic options to continue as a going concern.
Ongoing R&D tax rebates are expected based on past precedent and the nature of business activities in the next 12
months.
Management has prepared a cash flow forecast for the next 12 months, considering secured additional funding and
expected capital and operational inflows and outflows. Based on these forecasts, the group expects to have adequate
resources to continue in operational existence for beyond the next 12 months.
If the above plans do not come to fruition, then the company and group may not be able to continue as going concerns. In that
event, the carrying value of assets and liabilities may not be realised and settled at the amounts presented in the consolidated
statement of financial position.
Basis of preparation
These general purpose financial statements have been prepared in accordance with Australian Accounting Standards and
Interpretations issued by the Australian Accounting Standards Board ('AASB') and the Corporations Act 2001, as appropriate
for for-profit oriented entities. These financial statements also comply with International Financial Reporting Standards as
issued by the International Accounting Standards Board ('IASB').
Historical cost convention
The financial statements have been prepared under the historical cost convention, except for, where applicable, the
revaluation of financial assets and liabilities at fair value through profit or loss, financial assets at fair value through other
comprehensive income, investment properties, certain classes of property, plant and equipment and derivative financial
instruments.
Critical accounting estimates
The preparation of the financial statements requires the use of certain critical accounting estimates. It also requires
management to exercise its judgement in the process of applying the consolidated entity's accounting policies. The areas
involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the financial
statements, are disclosed in note 2.
Parent entity information
In accordance with the Corporations Act 2001, these financial statements present the results of the consolidated entity only.
Supplementary information about the parent entity is disclosed in note 27.
10
Tetratherix Pty Ltd
Notes to the consolidated financial statements
30 June 2023
Note 1. Material accounting policy information (continued)
Principles of consolidation
The consolidated financial statements incorporate the assets and liabilities of all subsidiaries of Tetratherix Pty Ltd ('company'
or 'parent entity') as at 30 June 2023 and the results of all subsidiaries for the year then ended. Tetratherix Pty Ltd and its
subsidiaries together are referred to in these financial statements as the 'consolidated entity'.
Subsidiaries are all those entities over which the consolidated entity has control. The consolidated entity controls an entity
when the consolidated entity is exposed to, or has rights to, variable returns from its involvement with the entity and has the
ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the
date on which control is transferred to the consolidated entity. They are de-consolidated from the date that control ceases.
Intercompany transactions, balances and unrealised gains on transactions between entities in the consolidated entity are
eliminated. Unrealised losses are also eliminated unless the transaction provides evidence of the impairment of the asset
transferred. Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies
adopted by the consolidated entity.
The acquisition of subsidiaries is accounted for using the acquisition method of accounting. A change in ownership interest,
without the loss of control, is accounted for as an equity transaction, where the difference between the consideration
transferred and the book value of the share of the non-controlling interest acquired is recognised directly in equity attributable
to the parent.
Where the consolidated entity loses control over a subsidiary, it derecognises the assets including goodwill, liabilities and noncontrolling interest in the subsidiary together with any cumulative translation differences recognised in equity. The consolidated
entity recognises the fair value of the consideration received and the fair value of any investment retained together with any
gain or loss in profit or loss.
Revenue recognition
The consolidated entity recognises revenue as follows:
Royalty income
The company is entitled to receive royalty and milestone payments in relation to a collaboration agreement with an external
party for the development, manufacturing, and industrialization of a product. The company retains ownership of the intellectual
property (IP) and has agreed to contribute to the product development process.
Milestone payments are due to the company for the use of the IP and upon achieving specific development and manufacturing
milestones, as outlined in the agreement.
Under AASB 15 – Revenue from Contracts with Customers, each milestone represents a separate performance obligation,
as each milestone provides distinct value to the customer and is separately identifiable in the agreement.
Revenue from milestone income is recognised at the point in time when the milestone is achieved, and the related performance
obligation is satisfied.
Interest
Interest revenue is recognised as interest accrues using the effective interest method. This is a method of calculating the
amortised cost of a financial asset and allocating the interest income over the relevant period using the effective interest rate,
which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to the
net carrying amount of the financial asset.
Other revenue
Other revenue is recognised when it is received or when the right to receive payment is established.
Government grants
Government grants relating to costs are deferred and recognised in profit or loss over the period necessary to match them
with the costs that they are intended to compensate.
11
Tetratherix Pty Ltd
Notes to the consolidated financial statements
30 June 2023
Note 1. Material accounting policy information (continued)
Income tax
The income tax expense or benefit for the period is the tax payable on that period's taxable income based on the applicable
income tax rate for each jurisdiction, adjusted by the changes in deferred tax assets and liabilities attributable to temporary
differences, unused tax losses and the adjustment recognised for prior periods, where applicable.
Deferred tax assets and liabilities are recognised for temporary differences at the tax rates expected to be applied when the
assets are recovered or liabilities are settled, based on those tax rates that are enacted or substantively enacted, except for:
When the deferred income tax asset or liability arises from the initial recognition of goodwill or an asset or liability in a
transaction that is not a business combination and that, at the time of the transaction, affects neither the accounting nor
taxable profits; or
When the taxable temporary difference is associated with interests in subsidiaries, associates or joint ventures, and the
timing of the reversal can be controlled and it is probable that the temporary difference will not reverse in the foreseeable
future.
Deferred tax assets are recognised for deductible temporary differences and unused tax losses only if it is probable that future
taxable amounts will be available to utilise those temporary differences and losses.
The carrying amount of recognised and unrecognised deferred tax assets are reviewed at each reporting date. Deferred tax
assets recognised are reduced to the extent that it is no longer probable that future taxable profits will be available for the
carrying amount to be recovered. Previously unrecognised deferred tax assets are recognised to the extent that it is probable
that there are future taxable profits available to recover the asset.
Deferred tax assets and liabilities are offset only where there is a legally enforceable right to offset current tax assets against
current tax liabilities and deferred tax assets against deferred tax liabilities; and they relate to the same taxable authority on
either the same taxable entity or different taxable entities which intend to settle simultaneously.
Current and non-current classification
Assets and liabilities are presented in the statement of financial position based on current and non-current classification.
An asset is classified as current when: it is either expected to be realised or intended to be sold or consumed in the
consolidated entity's normal operating cycle; it is held primarily for the purpose of trading; it is expected to be realised within
12 months after the reporting period; or the asset is cash or cash equivalent unless restricted from being exchanged or used
to settle a liability for at least 12 months after the reporting period. All other assets are classified as non-current.
A liability is classified as current when: it is either expected to be settled in the consolidated entity's normal operating cycle; it
is held primarily for the purpose of trading; it is due to be settled within 12 months after the reporting period; or there is no right
to defer the settlement of the liability for at least 12 months after the reporting period. All other liabilities are classified as noncurrent.
Deferred tax assets and liabilities are always classified as non-current.
Cash and cash equivalents
Cash and cash equivalents includes cash on hand, deposits held at call with financial institutions, other short-term, highly
liquid investments with original maturities of three months or less that are readily convertible to known amounts of cash and
which are subject to an insignificant risk of changes in value.
Trade and other receivables
Other receivables are recognised at amortised cost, less any allowance for expected credit losses.
Investment in joint ventures
A joint venture is a joint arrangement whereby the parties that have joint control of the arrangement have rights to the net
assets of the arrangement. Investments in joint ventures are accounted for using the equity method. Under the equity method,
the share of the profits or losses of the joint venture is recognised in profit or loss and the share of the movements in equity is
recognised in other comprehensive income. Investments in joint ventures are carried in the statement of financial position at
cost plus post-acquisition changes in the consolidated entity's share of net assets of the joint venture. Goodwill relating to the
joint venture is included in the carrying amount of the investment and is neither amortised nor individually tested for impairment.
Income earned from joint venture entities reduce the carrying amount of the investment.
12
Tetratherix Pty Ltd
Notes to the consolidated financial statements
30 June 2023
Note 1. Material accounting policy information (continued)
Property, plant and equipment
Plant and equipment is stated at historical cost less accumulated depreciation and impairment. Historical cost includes
expenditure that is directly attributable to the acquisition of the items.
Depreciation is calculated on a diminishing balance basis to write off the net cost of each item of property, plant and equipment
(excluding land) over their expected useful lives as follows:
Laboratory plant and equipment
Laboratory Furniture, fixtures and fittings
5-25 years
25 years
The residual values, useful lives and depreciation methods are reviewed, and adjusted if appropriate, at each reporting date.
An item of property, plant and equipment is derecognised upon disposal or when there is no future economic benefit to the
consolidated entity. Gains and losses between the carrying amount and the disposal proceeds are taken to profit or loss.
Right-of-use assets
A right-of-use asset is recognised at the commencement date of a lease. The right-of-use asset is measured at cost, which
comprises the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the
commencement date net of any lease incentives received, any initial direct costs incurred, and, except where included in the
cost of inventories, an estimate of costs expected to be incurred for dismantling and removing the underlying asset, and
restoring the site or asset.
Right-of-use assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life
of the asset, whichever is the shorter. Where the consolidated entity expects to obtain ownership of the leased asset at the
end of the lease term, the depreciation is over its estimated useful life. Right-of use assets are subject to impairment or
adjusted for any remeasurement of lease liabilities.
The consolidated entity has elected not to recognise a right-of-use asset and corresponding lease liability for short-term leases
with terms of 12 months or less and leases of low-value assets. Lease payments on these assets are expensed to profit or
loss as incurred.
Intangible assets
Intangible assets acquired as part of a business combination, other than goodwill, are initially measured at their fair value at
the date of the acquisition. Intangible assets acquired separately are initially recognised at cost. Indefinite life intangible assets
are not amortised and are subsequently measured at cost less any impairment. Finite life intangible assets are subsequently
measured at cost less amortisation and any impairment. The gains or losses recognised in profit or loss arising from the
derecognition of intangible assets are measured as the difference between net disposal proceeds and the carrying amount of
the intangible asset. The method and useful lives of finite life intangible assets are reviewed annually. Changes in the expected
pattern of consumption or useful life are accounted for prospectively by changing the amortisation method or period.
Trademarks
Significant costs associated with trademarks are deferred and amortised on a straight-line basis over the per
Share your feedback
Discover